Cooper Companies (NASDAQ:COO) Insider Holly Sheffield Buys 1,230 Shares

Key Points

  • Albert White III, CEO, purchased 10,000 Cooper Companies shares at an average price of $80.80 for $808,000, raising his holdings to 236,151 shares (a 4.42% increase).
  • The Board authorized a $2.00 billion stock repurchase program, allowing the company to buy back up to 15.4% of its shares.
  • Cooper beat quarterly expectations with $1.15 EPS (vs. $1.11 est.) and $1.07B revenue, and issued FY2026 guidance of $4.45–$4.60 EPS and Q1 guidance of $1.02–$1.04.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) insider Holly Sheffield acquired 1,230 shares of the stock in a transaction on Tuesday, December 16th. The shares were bought at an average price of $80.75 per share, with a total value of $99,322.50. Following the purchase, the insider directly owned 39,052 shares of the company's stock, valued at $3,153,449. The trade was a 3.25% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cooper Companies Trading Down 0.6%

NASDAQ COO opened at $81.04 on Wednesday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $100.24. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The stock's fifty day moving average price is $73.91 and its 200-day moving average price is $71.74. The stock has a market cap of $15.88 billion, a P/E ratio of 43.11, a P/E/G ratio of 2.33 and a beta of 1.05.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. Cooper Companies's revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.




Cooper Companies announced that its board has approved a share buyback plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

Analyst Ratings Changes

A number of equities analysts recently weighed in on COO shares. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an "equal weight" rating in a report on Friday, December 5th. Barclays reiterated an "overweight" rating and set a $91.00 target price on shares of Cooper Companies in a research note on Monday, December 8th. Piper Sandler restated an "overweight" rating and issued a $94.00 price target (up previously from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Cooper Companies in a research report on Monday. Finally, Citigroup reiterated a "neutral" rating and issued a $88.00 price objective (up from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $90.15.

Check Out Our Latest Research Report on COO

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Cooper Companies by 1.8% in the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company's stock valued at $1,725,963,000 after acquiring an additional 421,423 shares during the period. Capital World Investors increased its position in shares of Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company's stock valued at $723,417,000 after purchasing an additional 2,159,233 shares during the last quarter. State Street Corp lifted its stake in shares of Cooper Companies by 1.2% in the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company's stock worth $616,227,000 after purchasing an additional 104,910 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock worth $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Cooper Companies by 2.5% in the second quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company's stock worth $368,893,000 after buying an additional 127,907 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Cooper Companies?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cooper Companies and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles